首页> 外文期刊>Molecular genetics and genomics: MGG >Characterization of two novel Alu element-mediated alpha-globin gene cluster deletions causing alpha(0)-thalassemia by targeted next-generation sequencing
【24h】

Characterization of two novel Alu element-mediated alpha-globin gene cluster deletions causing alpha(0)-thalassemia by targeted next-generation sequencing

机译:两种新型Alu元素介导的α-珠蛋白基因簇缺失引起α(0)的靶向下一代测序

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

alpha-thalassemia is an inherited blood disorder commonly caused by deletions or point mutations involving one or both alpha-globin genes. Recent studies shed new light on the critical role of upstream enhancers multi-species conserved sequences (MCSs) in the ordered regulation of alpha-globin gene expression. Herein, we reported two unrelated probands with deletions in alpha-globin genes and MCSs, respectively. The proband from Family A is a compound heterozygote carrying a known alpha(+) mutation (-alpha(3.7)) and a novel 60.2 kb deletion causing the absence of both alpha-globin genes. The proband from Family B, on the other hand, is a compound heterozygote with a known alpha(0) mutation (--(SEA)) and a novel deletion involving only upstream regulatory elements MCS-R1, R2 and R3, while the alpha-globin genes remain intact. Notably, both these two patients suffered varied extent of anemia, indicating that the loss of enhancer elements could equally lead to reduced synthesis of alpha-globin. Upon these observations, we then confirmed the exact breakpoints of these two novel deletions using a targeted next-generation sequencing (NGS) previously established by our group, which may enable further elucidation of the rearrangement mechanisms on these deletions and functional dissection of MCSs. Taken together, our study reports a reliable NGS-based molecular screening approach for accurate identification of copy number variations (CNVs) in the alpha-globin cluster and the genetic diagnosis of these two probands may help to extend the spectrum of alpha-thalassemia mutations in Chinese population.
机译:α-地中海贫血是一种常见的血液障碍,通常是由缺失或缺乏α-珠蛋白基因的缺失突变引起的。最近的研究揭示了在α-珠蛋白基因表达的有序调节中的上游增强子多种保守序列(MCS)的关键作用。在此,我们分别报道了两个不相关的证书,分别在α-珠蛋白基因和MCS中缺失。从A族先证者是携带已知的α的化合物杂合子(+)突变(-alpha(3.7))和新的60.2 kb的缺失导致均缺席的α-珠蛋白基因的。从家族B先证者,在另一方面,是与已知的α(0)突变的复合杂( - (SEA))和仅涉及上游调控元件MCS-R1,R2和R3的新颖缺失,而α -globin基因保持完整。值得注意的是,这两名患者都遭受了多种贫血程度,表明增强子元素的丧失同样可以降低α-珠蛋白的合成。这些观察,我们随后使用靶向下一代测序(NGS)先前由我们的基团,其可以使得能够对这些缺失和的MCS的功能解剖重排机制的进一步阐明建立证实这两个新颖缺失的确切断点。总之,我们的研究报告为α-珠簇和这两个先证者的基因诊断在拷贝数变异(CNV)的准确识别的基于NGS可靠的分子筛选方法可有助于延长α地中海贫血突变的频谱在中国人口。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号